TORQUE Trademark

Trademark Overview


On Wednesday, March 16, 2022, a trademark application was filed for TORQUE with the United States Patent and Trademark Office. The USPTO has given the TORQUE trademark a serial number of 97315865. The federal status of this trademark filing is REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED as of Wednesday, November 15, 2023. This trademark is owned by Torque Bio, Inc.. The TORQUE trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for use in gene therapy; biological preparations for use in gene therapy; biological and pharmaceutical preparations, both comprised of therapeutic nucleic acids, namely, RNA, for the treatment and prevention of genetic diseases and disorders, genomic diseases and disorders, neurological diseases and disorders, cardiological diseases and disorders, musculoskeletal diseases and disorders, cancer, infectious diseases, and immune system related diseases and disorders, metabolic diseases and disorders, hematological diseases and disorders, reproductive diseases and disorders, gynecological diseases and disorders, inflammatory diseases and disorders, respiratory diseases and disorders, gastroenterological diseases and disorders, ophthalmological diseases and disorders, and dermatological diseases and disorders; pharmaceutical preparations for treating metabolic diseases and disorders, hematological diseases and disorders, reproductive diseases and disorders, gyne...

Testing, inspection, research, and development of pharmaceutical preparations and biological preparations for gene therapy; Pharmaceutical research and development in the field of gene therapy; Biological research and development in the field of gene therapy; consulting services in the fields of biotechnology, pharmaceutical research and development, and in the field of genetic science; custom design and development of biochemical reagents, namely, for use in the synthesis for others of clinical medical reagents for use in gene therapy; development of pharmaceutical preparations for use in gene therapy and gene delivery technology; development of products being genetic therapies; scientific research in the field of genetic engineering, biotechnology research services, and research and development of new products in the field of gene therapeutics and research tools; research and development in the biotechnology field; scientific and medical research and development in the fields of gene...
torque

General Information


Serial Number97315865
Word MarkTORQUE
Filing DateWednesday, March 16, 2022
Status654 - REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED
Status DateWednesday, November 15, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical preparations for use in gene therapy; biological preparations for use in gene therapy; biological and pharmaceutical preparations, both comprised of therapeutic nucleic acids, namely, RNA, for the treatment and prevention of genetic diseases and disorders, genomic diseases and disorders, neurological diseases and disorders, cardiological diseases and disorders, musculoskeletal diseases and disorders, cancer, infectious diseases, and immune system related diseases and disorders, metabolic diseases and disorders, hematological diseases and disorders, reproductive diseases and disorders, gynecological diseases and disorders, inflammatory diseases and disorders, respiratory diseases and disorders, gastroenterological diseases and disorders, ophthalmological diseases and disorders, and dermatological diseases and disorders; pharmaceutical preparations for treating metabolic diseases and disorders, hematological diseases and disorders, reproductive diseases and disorders, gynecological diseases and disorders, inflammatory diseases and disorders, respiratory diseases and disorders, gastroenterological diseases and disorders, ophthalmological diseases and disorders, and dermatological diseases and disorders, metabolic diseases and disorders, hematological diseases and disorders, reproductive diseases and disorders, gynecological diseases and disorders, inflammatory diseases and disorders, respiratory diseases and disorders, gastroenterological diseases and disorders, ophthalmological diseases and disorders, and dermatological diseases and disorders
Goods and ServicesTesting, inspection, research, and development of pharmaceutical preparations and biological preparations for gene therapy; Pharmaceutical research and development in the field of gene therapy; Biological research and development in the field of gene therapy; consulting services in the fields of biotechnology, pharmaceutical research and development, and in the field of genetic science; custom design and development of biochemical reagents, namely, for use in the synthesis for others of clinical medical reagents for use in gene therapy; development of pharmaceutical preparations for use in gene therapy and gene delivery technology; development of products being genetic therapies; scientific research in the field of genetic engineering, biotechnology research services, and research and development of new products in the field of gene therapeutics and research tools; research and development in the biotechnology field; scientific and medical research and development in the fields of genetic diseases and disorders, genomic diseases and disorders, neurological diseases and disorders, cardiological diseases and disorders, musculoskeletal diseases and disorders, cancer, infectious diseases, and immune system related diseases and disorders, metabolic diseases and disorders, hematological diseases and disorders, reproductive diseases and disorders, gynecological diseases and disorders, inflammatory diseases and disorders, respiratory diseases and disorders, gastroenterological diseases and disorders, ophthalmological diseases and disorders, and dermatological diseases and disorders of autoimmune, cancer, cardiovascular, central nervous system, diabetic, dermatological, endocrine, fungal, gastrointestinal, hematologic, hepatological, immunological, infectious, inflammatory, liver, menopausal, metabolic, musculoskeletal, neurological, ophthalmologic, orthopedic, pain, peripheral nervous system, psychiatric, respiratory, renal, urogenital, urological, and viral diseases and disorders and complications associated therewith; scientific research and product development services for others in the pharmaceutical, biotechnology, medical and agriculture fields; testing, inspection, research, or development of pharmaceutical preparations for gene therapy and gene delivery technology; biomedical research and development, scientific research and development, pharmaceutical research and development and product development services in the fields of genome editing, gene editing, genome engineering, gene modulation, genetic diseases, gene therapy, and cell therapy; product development in the fields of genetic therapies, gene delivery technologies, and effectors to regulate, modulate, and characterize disease states; conducting clinical trials for others in the field of gene therapy design and delivery; biomedical research in the field of gene therapy design and delivery; gene therapy design and development of gene therapy delivery through use of biochemical assays; biomedical research and development, scientific research and development, pharmaceutical research and development and product development in the fields of genetic diseases and disorders, genomic diseases and disorders, neurological diseases and disorders, cardiological diseases and disorders, musculoskeletal diseases and disorders, cancer, infectious diseases, and immune system related diseases and disorders, metabolic diseases and disorders, hematological diseases and disorders, reproductive diseases and disorders, gynecological diseases and disorders, inflammatory diseases and disorders, respiratory diseases and disorders, gastroenterological diseases and disorders, ophthalmological diseases and disorders, and dermatological diseases and disorders autoimmune, cancer, cardiovascular, central nervous system, diabetic, dermatological, endocrine, fungal, gastrointestinal, hematologic, hepatological, immunological, infectious, inflammatory, liver, menopausal, metabolic, musculoskeletal, neurological, ophthalmologic, orthopedic, pain, peripheral nervous system, psychiatric, respiratory, renal, urogenital, urological, and viral diseases and disorders; medical research services, namely, scientific research in the fields of genetic engineering and gene therapy services

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 22, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, March 22, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTorque Bio, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWestlake Village, CA 91361

Trademark Events


Event DateEvent Description
Wednesday, November 15, 2023REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, May 2, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, May 2, 2023LETTER OF SUSPENSION E-MAILED
Tuesday, May 2, 2023SUSPENSION LETTER WRITTEN
Tuesday, March 28, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 27, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 27, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, December 30, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, December 30, 2022NON-FINAL ACTION E-MAILED
Friday, December 30, 2022NON-FINAL ACTION WRITTEN
Tuesday, December 27, 2022ASSIGNED TO EXAMINER
Tuesday, March 22, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, March 19, 2022NEW APPLICATION ENTERED